Global Duchenne Muscular Dystrophy Therapeutics Market Size, Status and Forecast 2022
This report studies the global Duchenne Muscular Dystrophy Therapeutics market, analyzes and researches the Duchenne Muscular Dystrophy Therapeutics development status and forecast in United States, EU, Japan, China, India and Southeast Asia.
This report focuses on the top players in global market, like
This report focuses on the top players in global market, like
- Bristol-Myers Squibb Company
- FibroGen
- ITALFARMACO
- Marathon Pharmaceuticals
- NS Pharma
- PTC Therapeutics
- Pfizer
- ReveraGen BioPharma
- Santhera Pharmaceuticals
- Sarepta Therapeutics
- United States
- EU
- Japan
- China
- India
- Southeast Asia
- Pain Management Drugs
- Corticosteroids
- Prednisolone
- Prednisone
- Deflazacort
- Hospitals
- Clinics
- Home Care Settings
Global Duchenne Muscular Dystrophy Therapeutics Market Size, Status and Forecast 2022
1 INDUSTRY OVERVIEW OF DUCHENNE MUSCULAR DYSTROPHY THERAPEUTICS
1.1 Duchenne Muscular Dystrophy Therapeutics Market Overview
1.1.1 Duchenne Muscular Dystrophy Therapeutics Product Scope
1.1.2 Market Status and Outlook
1.2 Global Duchenne Muscular Dystrophy Therapeutics Market Size and Analysis by Regions
1.2.1 United States
1.2.2 EU
1.2.3 Japan
1.2.4 China
1.2.5 India
1.2.6 Southeast Asia
1.3 Duchenne Muscular Dystrophy Therapeutics Market by Type
1.3.1 Pain Management Drugs
1.3.2 Corticosteroids
1.3.3 Prednisolone
1.3.4 Prednisone
1.3.5 Deflazacort
1.4 Duchenne Muscular Dystrophy Therapeutics Market by End Users/Application
1.4.1 Hospitals
1.4.2 Clinics
1.4.3 Home Care Settings
2 GLOBAL DUCHENNE MUSCULAR DYSTROPHY THERAPEUTICS COMPETITION ANALYSIS BY PLAYERS
2.1 Duchenne Muscular Dystrophy Therapeutics Market Size (Value) by Players (2016 and 2017)
2.2 Competitive Status and Trend
2.2.1 Market Concentration Rate
2.2.2 Product/Service Differences
2.2.3 New Entrants
2.2.4 The Technology Trends in Future
3 COMPANY (TOP PLAYERS) PROFILES
3.1 Bristol-Myers Squibb Company
3.1.1 Company Profile
3.1.2 Main Business/Business Overview
3.1.3 Products, Services and Solutions
3.1.4 Duchenne Muscular Dystrophy Therapeutics Revenue (Value) (2012-2017)
3.1.5 Recent Developments
3.2 FibroGen
3.2.1 Company Profile
3.2.2 Main Business/Business Overview
3.2.3 Products, Services and Solutions
3.2.4 Duchenne Muscular Dystrophy Therapeutics Revenue (Value) (2012-2017)
3.2.5 Recent Developments
3.3 ITALFARMACO
3.3.1 Company Profile
3.3.2 Main Business/Business Overview
3.3.3 Products, Services and Solutions
3.3.4 Duchenne Muscular Dystrophy Therapeutics Revenue (Value) (2012-2017)
3.3.5 Recent Developments
3.4 Marathon Pharmaceuticals
3.4.1 Company Profile
3.4.2 Main Business/Business Overview
3.4.3 Products, Services and Solutions
3.4.4 Duchenne Muscular Dystrophy Therapeutics Revenue (Value) (2012-2017)
3.4.5 Recent Developments
3.5 NS Pharma
3.5.1 Company Profile
3.5.2 Main Business/Business Overview
3.5.3 Products, Services and Solutions
3.5.4 Duchenne Muscular Dystrophy Therapeutics Revenue (Value) (2012-2017)
3.5.5 Recent Developments
3.6 PTC Therapeutics
3.6.1 Company Profile
3.6.2 Main Business/Business Overview
3.6.3 Products, Services and Solutions
3.6.4 Duchenne Muscular Dystrophy Therapeutics Revenue (Value) (2012-2017)
3.6.5 Recent Developments
3.7 Pfizer
3.7.1 Company Profile
3.7.2 Main Business/Business Overview
3.7.3 Products, Services and Solutions
3.7.4 Duchenne Muscular Dystrophy Therapeutics Revenue (Value) (2012-2017)
3.7.5 Recent Developments
3.8 ReveraGen BioPharma
3.8.1 Company Profile
3.8.2 Main Business/Business Overview
3.8.3 Products, Services and Solutions
3.8.4 Duchenne Muscular Dystrophy Therapeutics Revenue (Value) (2012-2017)
3.8.5 Recent Developments
3.9 Santhera Pharmaceuticals
3.9.1 Company Profile
3.9.2 Main Business/Business Overview
3.9.3 Products, Services and Solutions
3.9.4 Duchenne Muscular Dystrophy Therapeutics Revenue (Value) (2012-2017)
3.9.5 Recent Developments
3.10 Sarepta Therapeutics
3.10.1 Company Profile
3.10.2 Main Business/Business Overview
3.10.3 Products, Services and Solutions
3.10.4 Duchenne Muscular Dystrophy Therapeutics Revenue (Value) (2012-2017)
3.10.5 Recent Developments
4 GLOBAL DUCHENNE MUSCULAR DYSTROPHY THERAPEUTICS MARKET SIZE BY TYPE AND APPLICATION (2012-2017)
4.1 Global Duchenne Muscular Dystrophy Therapeutics Market Size by Type (2012-2017)
4.2 Global Duchenne Muscular Dystrophy Therapeutics Market Size by Application (2012-2017)
4.3 Potential Application of Duchenne Muscular Dystrophy Therapeutics in Future
4.4 Top Consumer/End Users of Duchenne Muscular Dystrophy Therapeutics
5 UNITED STATES DUCHENNE MUSCULAR DYSTROPHY THERAPEUTICS DEVELOPMENT STATUS AND OUTLOOK
5.1 United States Duchenne Muscular Dystrophy Therapeutics Market Size (2012-2017)
5.2 United States Duchenne Muscular Dystrophy Therapeutics Market Size and Market Share by Players (2016 and 2017)
6 EU DUCHENNE MUSCULAR DYSTROPHY THERAPEUTICS DEVELOPMENT STATUS AND OUTLOOK
6.1 EU Duchenne Muscular Dystrophy Therapeutics Market Size (2012-2017)
6.2 EU Duchenne Muscular Dystrophy Therapeutics Market Size and Market Share by Players (2016 and 2017)
7 JAPAN DUCHENNE MUSCULAR DYSTROPHY THERAPEUTICS DEVELOPMENT STATUS AND OUTLOOK
7.1 Japan Duchenne Muscular Dystrophy Therapeutics Market Size (2012-2017)
7.2 Japan Duchenne Muscular Dystrophy Therapeutics Market Size and Market Share by Players (2016 and 2017)
8 CHINA DUCHENNE MUSCULAR DYSTROPHY THERAPEUTICS DEVELOPMENT STATUS AND OUTLOOK
8.1 China Duchenne Muscular Dystrophy Therapeutics Market Size (2012-2017)
8.2 China Duchenne Muscular Dystrophy Therapeutics Market Size and Market Share by Players (2016 and 2017)
9 INDIA DUCHENNE MUSCULAR DYSTROPHY THERAPEUTICS DEVELOPMENT STATUS AND OUTLOOK
9.1 India Duchenne Muscular Dystrophy Therapeutics Market Size (2012-2017)
9.2 India Duchenne Muscular Dystrophy Therapeutics Market Size and Market Share by Players (2016 and 2017)
10 SOUTHEAST ASIA DUCHENNE MUSCULAR DYSTROPHY THERAPEUTICS DEVELOPMENT STATUS AND OUTLOOK
10.1 Southeast Asia Duchenne Muscular Dystrophy Therapeutics Market Size (2012-2017)
10.2 Southeast Asia Duchenne Muscular Dystrophy Therapeutics Market Size and Market Share by Players (2016 and 2017)
11 MARKET FORECAST BY REGIONS, TYPE AND APPLICATION (2017-2022)
11.1 Global Duchenne Muscular Dystrophy Therapeutics Market Size (Value) by Regions (2017-2022)
11.1.1 United States Duchenne Muscular Dystrophy Therapeutics Revenue and Growth Rate (2017-2022)
11.1.2 EU Duchenne Muscular Dystrophy Therapeutics Revenue and Growth Rate (2017-2022)
11.1.3 Japan Duchenne Muscular Dystrophy Therapeutics Revenue and Growth Rate (2017-2022)
11.1.4 China Duchenne Muscular Dystrophy Therapeutics Revenue and Growth Rate (2017-2022)
11.1.5 India Duchenne Muscular Dystrophy Therapeutics Revenue and Growth Rate (2017-2022)
11.1.6 Southeast Asia Duchenne Muscular Dystrophy Therapeutics Revenue and Growth Rate (2017-2022)
11.2 Global Duchenne Muscular Dystrophy Therapeutics Market Size (Value) by Type (2017-2022)
11.3 Global Duchenne Muscular Dystrophy Therapeutics Market Size by Application (2017-2022)
12 DUCHENNE MUSCULAR DYSTROPHY THERAPEUTICS MARKET DYNAMICS
12.1 Duchenne Muscular Dystrophy Therapeutics Market Opportunities
12.2 Duchenne Muscular Dystrophy Therapeutics Challenge and Risk
12.2.1 Competition from Opponents
12.2.2 Downside Risks of Economy
12.3 Duchenne Muscular Dystrophy Therapeutics Market Constraints and Threat
12.3.1 Threat from Substitute
12.3.2 Government Policy
12.3.3 Technology Risks
12.4 Duchenne Muscular Dystrophy Therapeutics Market Driving Force
12.4.1 Growing Demand from Emerging Markets
12.4.2 Potential Application
13 MARKET EFFECT FACTORS ANALYSIS
13.1 Technology Progress/Risk
13.1.1 Substitutes
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs Trend/Customer Preference
13.3 External Environmental Change
13.3.1 Economic Fluctuations
13.3.2 Other Risk Factors
14 RESEARCH FINDING/CONCLUSION
15 APPENDIX
Methodology
Analyst Introduction
Data Source
The report requires updating with new data and is sent in 2-3 business days after order is placed.
1 INDUSTRY OVERVIEW OF DUCHENNE MUSCULAR DYSTROPHY THERAPEUTICS
1.1 Duchenne Muscular Dystrophy Therapeutics Market Overview
1.1.1 Duchenne Muscular Dystrophy Therapeutics Product Scope
1.1.2 Market Status and Outlook
1.2 Global Duchenne Muscular Dystrophy Therapeutics Market Size and Analysis by Regions
1.2.1 United States
1.2.2 EU
1.2.3 Japan
1.2.4 China
1.2.5 India
1.2.6 Southeast Asia
1.3 Duchenne Muscular Dystrophy Therapeutics Market by Type
1.3.1 Pain Management Drugs
1.3.2 Corticosteroids
1.3.3 Prednisolone
1.3.4 Prednisone
1.3.5 Deflazacort
1.4 Duchenne Muscular Dystrophy Therapeutics Market by End Users/Application
1.4.1 Hospitals
1.4.2 Clinics
1.4.3 Home Care Settings
2 GLOBAL DUCHENNE MUSCULAR DYSTROPHY THERAPEUTICS COMPETITION ANALYSIS BY PLAYERS
2.1 Duchenne Muscular Dystrophy Therapeutics Market Size (Value) by Players (2016 and 2017)
2.2 Competitive Status and Trend
2.2.1 Market Concentration Rate
2.2.2 Product/Service Differences
2.2.3 New Entrants
2.2.4 The Technology Trends in Future
3 COMPANY (TOP PLAYERS) PROFILES
3.1 Bristol-Myers Squibb Company
3.1.1 Company Profile
3.1.2 Main Business/Business Overview
3.1.3 Products, Services and Solutions
3.1.4 Duchenne Muscular Dystrophy Therapeutics Revenue (Value) (2012-2017)
3.1.5 Recent Developments
3.2 FibroGen
3.2.1 Company Profile
3.2.2 Main Business/Business Overview
3.2.3 Products, Services and Solutions
3.2.4 Duchenne Muscular Dystrophy Therapeutics Revenue (Value) (2012-2017)
3.2.5 Recent Developments
3.3 ITALFARMACO
3.3.1 Company Profile
3.3.2 Main Business/Business Overview
3.3.3 Products, Services and Solutions
3.3.4 Duchenne Muscular Dystrophy Therapeutics Revenue (Value) (2012-2017)
3.3.5 Recent Developments
3.4 Marathon Pharmaceuticals
3.4.1 Company Profile
3.4.2 Main Business/Business Overview
3.4.3 Products, Services and Solutions
3.4.4 Duchenne Muscular Dystrophy Therapeutics Revenue (Value) (2012-2017)
3.4.5 Recent Developments
3.5 NS Pharma
3.5.1 Company Profile
3.5.2 Main Business/Business Overview
3.5.3 Products, Services and Solutions
3.5.4 Duchenne Muscular Dystrophy Therapeutics Revenue (Value) (2012-2017)
3.5.5 Recent Developments
3.6 PTC Therapeutics
3.6.1 Company Profile
3.6.2 Main Business/Business Overview
3.6.3 Products, Services and Solutions
3.6.4 Duchenne Muscular Dystrophy Therapeutics Revenue (Value) (2012-2017)
3.6.5 Recent Developments
3.7 Pfizer
3.7.1 Company Profile
3.7.2 Main Business/Business Overview
3.7.3 Products, Services and Solutions
3.7.4 Duchenne Muscular Dystrophy Therapeutics Revenue (Value) (2012-2017)
3.7.5 Recent Developments
3.8 ReveraGen BioPharma
3.8.1 Company Profile
3.8.2 Main Business/Business Overview
3.8.3 Products, Services and Solutions
3.8.4 Duchenne Muscular Dystrophy Therapeutics Revenue (Value) (2012-2017)
3.8.5 Recent Developments
3.9 Santhera Pharmaceuticals
3.9.1 Company Profile
3.9.2 Main Business/Business Overview
3.9.3 Products, Services and Solutions
3.9.4 Duchenne Muscular Dystrophy Therapeutics Revenue (Value) (2012-2017)
3.9.5 Recent Developments
3.10 Sarepta Therapeutics
3.10.1 Company Profile
3.10.2 Main Business/Business Overview
3.10.3 Products, Services and Solutions
3.10.4 Duchenne Muscular Dystrophy Therapeutics Revenue (Value) (2012-2017)
3.10.5 Recent Developments
4 GLOBAL DUCHENNE MUSCULAR DYSTROPHY THERAPEUTICS MARKET SIZE BY TYPE AND APPLICATION (2012-2017)
4.1 Global Duchenne Muscular Dystrophy Therapeutics Market Size by Type (2012-2017)
4.2 Global Duchenne Muscular Dystrophy Therapeutics Market Size by Application (2012-2017)
4.3 Potential Application of Duchenne Muscular Dystrophy Therapeutics in Future
4.4 Top Consumer/End Users of Duchenne Muscular Dystrophy Therapeutics
5 UNITED STATES DUCHENNE MUSCULAR DYSTROPHY THERAPEUTICS DEVELOPMENT STATUS AND OUTLOOK
5.1 United States Duchenne Muscular Dystrophy Therapeutics Market Size (2012-2017)
5.2 United States Duchenne Muscular Dystrophy Therapeutics Market Size and Market Share by Players (2016 and 2017)
6 EU DUCHENNE MUSCULAR DYSTROPHY THERAPEUTICS DEVELOPMENT STATUS AND OUTLOOK
6.1 EU Duchenne Muscular Dystrophy Therapeutics Market Size (2012-2017)
6.2 EU Duchenne Muscular Dystrophy Therapeutics Market Size and Market Share by Players (2016 and 2017)
7 JAPAN DUCHENNE MUSCULAR DYSTROPHY THERAPEUTICS DEVELOPMENT STATUS AND OUTLOOK
7.1 Japan Duchenne Muscular Dystrophy Therapeutics Market Size (2012-2017)
7.2 Japan Duchenne Muscular Dystrophy Therapeutics Market Size and Market Share by Players (2016 and 2017)
8 CHINA DUCHENNE MUSCULAR DYSTROPHY THERAPEUTICS DEVELOPMENT STATUS AND OUTLOOK
8.1 China Duchenne Muscular Dystrophy Therapeutics Market Size (2012-2017)
8.2 China Duchenne Muscular Dystrophy Therapeutics Market Size and Market Share by Players (2016 and 2017)
9 INDIA DUCHENNE MUSCULAR DYSTROPHY THERAPEUTICS DEVELOPMENT STATUS AND OUTLOOK
9.1 India Duchenne Muscular Dystrophy Therapeutics Market Size (2012-2017)
9.2 India Duchenne Muscular Dystrophy Therapeutics Market Size and Market Share by Players (2016 and 2017)
10 SOUTHEAST ASIA DUCHENNE MUSCULAR DYSTROPHY THERAPEUTICS DEVELOPMENT STATUS AND OUTLOOK
10.1 Southeast Asia Duchenne Muscular Dystrophy Therapeutics Market Size (2012-2017)
10.2 Southeast Asia Duchenne Muscular Dystrophy Therapeutics Market Size and Market Share by Players (2016 and 2017)
11 MARKET FORECAST BY REGIONS, TYPE AND APPLICATION (2017-2022)
11.1 Global Duchenne Muscular Dystrophy Therapeutics Market Size (Value) by Regions (2017-2022)
11.1.1 United States Duchenne Muscular Dystrophy Therapeutics Revenue and Growth Rate (2017-2022)
11.1.2 EU Duchenne Muscular Dystrophy Therapeutics Revenue and Growth Rate (2017-2022)
11.1.3 Japan Duchenne Muscular Dystrophy Therapeutics Revenue and Growth Rate (2017-2022)
11.1.4 China Duchenne Muscular Dystrophy Therapeutics Revenue and Growth Rate (2017-2022)
11.1.5 India Duchenne Muscular Dystrophy Therapeutics Revenue and Growth Rate (2017-2022)
11.1.6 Southeast Asia Duchenne Muscular Dystrophy Therapeutics Revenue and Growth Rate (2017-2022)
11.2 Global Duchenne Muscular Dystrophy Therapeutics Market Size (Value) by Type (2017-2022)
11.3 Global Duchenne Muscular Dystrophy Therapeutics Market Size by Application (2017-2022)
12 DUCHENNE MUSCULAR DYSTROPHY THERAPEUTICS MARKET DYNAMICS
12.1 Duchenne Muscular Dystrophy Therapeutics Market Opportunities
12.2 Duchenne Muscular Dystrophy Therapeutics Challenge and Risk
12.2.1 Competition from Opponents
12.2.2 Downside Risks of Economy
12.3 Duchenne Muscular Dystrophy Therapeutics Market Constraints and Threat
12.3.1 Threat from Substitute
12.3.2 Government Policy
12.3.3 Technology Risks
12.4 Duchenne Muscular Dystrophy Therapeutics Market Driving Force
12.4.1 Growing Demand from Emerging Markets
12.4.2 Potential Application
13 MARKET EFFECT FACTORS ANALYSIS
13.1 Technology Progress/Risk
13.1.1 Substitutes
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs Trend/Customer Preference
13.3 External Environmental Change
13.3.1 Economic Fluctuations
13.3.2 Other Risk Factors
14 RESEARCH FINDING/CONCLUSION
15 APPENDIX
Methodology
Analyst Introduction
Data Source
The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES
Figure Duchenne Muscular Dystrophy Therapeutics Product Scope
Figure Global Duchenne Muscular Dystrophy Therapeutics Market Size (Million USD) (2012-2017)
Table Global Duchenne Muscular Dystrophy Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Global Duchenne Muscular Dystrophy Therapeutics Market Share by Regions in 2016
Figure United States Duchenne Muscular Dystrophy Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure EU Duchenne Muscular Dystrophy Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Japan Duchenne Muscular Dystrophy Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure China Duchenne Muscular Dystrophy Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure India Duchenne Muscular Dystrophy Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Southeast Asia Duchenne Muscular Dystrophy Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Global Duchenne Muscular Dystrophy Therapeutics Market Share by Type in 2016
Figure Pain Management Drugs Market Size (Million USD) and Growth Rate (2012-2017)
Figure Corticosteroids Market Size (Million USD) and Growth Rate (2012-2017)
Figure Prednisolone Market Size (Million USD) and Growth Rate (2012-2017)
Figure Prednisone Market Size (Million USD) and Growth Rate (2012-2017)
Figure Deflazacort Market Size (Million USD) and Growth Rate (2012-2017)
Figure Global Duchenne Muscular Dystrophy Therapeutics Market Share by Application in 2016
Table Key Downstream Customer in Hospitals
Figure Duchenne Muscular Dystrophy Therapeutics Market Size (Million USD) and Growth Rate in Hospitals (2012-2017)
Table Key Downstream Customer in Clinics
Figure Duchenne Muscular Dystrophy Therapeutics Market Size (Million USD) and Growth Rate in Clinics (2012-2017)
Table Key Downstream Customer in Home Care Settings
Figure Duchenne Muscular Dystrophy Therapeutics Market Size (Million USD) and Growth Rate in Home Care Settings (2012-2017)
Table Duchenne Muscular Dystrophy Therapeutics Market Size (Million USD) by Players (2016 and 2017)
Figure Duchenne Muscular Dystrophy Therapeutics Market Size Share by Players in 2016
Figure Duchenne Muscular Dystrophy Therapeutics Market Size Share by Players in 2017
Table Bristol-Myers Squibb Company Basic Information List
Table Duchenne Muscular Dystrophy Therapeutics Business Revenue (Million USD) of Bristol-Myers Squibb Company (2012-2017)
Figure Bristol-Myers Squibb Company Duchenne Muscular Dystrophy Therapeutics Business Revenue Market Share in 2016
Table FibroGen Basic Information List
Table Duchenne Muscular Dystrophy Therapeutics Business Revenue (Million USD) of FibroGen (2012-2017)
Figure FibroGen Duchenne Muscular Dystrophy Therapeutics Business Revenue Market Share in 2016
Table ITALFARMACO Basic Information List
Table Duchenne Muscular Dystrophy Therapeutics Business Revenue (Million USD) of ITALFARMACO (2012-2017)
Figure ITALFARMACO Duchenne Muscular Dystrophy Therapeutics Business Revenue Market Share in 2016
Table Marathon Pharmaceuticals Basic Information List
Table Duchenne Muscular Dystrophy Therapeutics Business Revenue (Million USD) of Marathon Pharmaceuticals (2012-2017)
Figure Marathon Pharmaceuticals Duchenne Muscular Dystrophy Therapeutics Business Revenue Market Share in 2016
Table NS Pharma Basic Information List
Table Duchenne Muscular Dystrophy Therapeutics Business Revenue (Million USD) of NS Pharma (2012-2017)
Figure NS Pharma Duchenne Muscular Dystrophy Therapeutics Business Revenue Market Share in 2016
Table PTC Therapeutics Basic Information List
Table Duchenne Muscular Dystrophy Therapeutics Business Revenue (Million USD) of PTC Therapeutics (2012-2017)
Figure PTC Therapeutics Duchenne Muscular Dystrophy Therapeutics Business Revenue Market Share in 2016
Table Pfizer Basic Information List
Table Duchenne Muscular Dystrophy Therapeutics Business Revenue (Million USD) of Pfizer (2012-2017)
Figure Pfizer Duchenne Muscular Dystrophy Therapeutics Business Revenue Market Share in 2016
Table ReveraGen BioPharma Basic Information List
Table Duchenne Muscular Dystrophy Therapeutics Business Revenue (Million USD) of ReveraGen BioPharma (2012-2017)
Figure ReveraGen BioPharma Duchenne Muscular Dystrophy Therapeutics Business Revenue Market Share in 2016
Table Santhera Pharmaceuticals Basic Information List
Table Duchenne Muscular Dystrophy Therapeutics Business Revenue (Million USD) of Santhera Pharmaceuticals (2012-2017)
Figure Santhera Pharmaceuticals Duchenne Muscular Dystrophy Therapeutics Business Revenue Market Share in 2016
Table Sarepta Therapeutics Basic Information List
Table Duchenne Muscular Dystrophy Therapeutics Business Revenue (Million USD) of Sarepta Therapeutics (2012-2017)
Figure Sarepta Therapeutics Duchenne Muscular Dystrophy Therapeutics Business Revenue Market Share in 2016
Table Global Duchenne Muscular Dystrophy Therapeutics Market Size (Million USD) by Type (2012-2017)
Figure Global Duchenne Muscular Dystrophy Therapeutics Market Size Share by Type in 2012
Figure Global Duchenne Muscular Dystrophy Therapeutics Market Size Share by Type in 2013
Figure Global Duchenne Muscular Dystrophy Therapeutics Market Size Share by Type in 2014
Figure Global Duchenne Muscular Dystrophy Therapeutics Market Size Share by Type in 2015
Figure Global Duchenne Muscular Dystrophy Therapeutics Market Size Share by Type in 2016
Figure Global Duchenne Muscular Dystrophy Therapeutics Market Size Share by Type in 2017
Table Global Duchenne Muscular Dystrophy Therapeutics Market Size (Million USD) by Application (2012-2017)
Figure Global Duchenne Muscular Dystrophy Therapeutics Market Size (Million USD) by Application in 2012
Figure Global Duchenne Muscular Dystrophy Therapeutics Market Size (Million USD) by Application in 2013
Figure Global Duchenne Muscular Dystrophy Therapeutics Market Size (Million USD) by Application in 2014
Figure Global Duchenne Muscular Dystrophy Therapeutics Market Size (Million USD) by Application in 2015
Figure Global Duchenne Muscular Dystrophy Therapeutics Market Size (Million USD) by Application in 2016
Figure Global Duchenne Muscular Dystrophy Therapeutics Market Size (Million USD) by Application in 2017
Table Top Consumer/End Users of Duchenne Muscular Dystrophy Therapeutics
Figure United States Duchenne Muscular Dystrophy Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table United States Duchenne Muscular Dystrophy Therapeutics Market Size (Million USD) by Players (2012-2017)
Figure United States Duchenne Muscular Dystrophy Therapeutics Market Size Share by Players in 2016
Figure United States Duchenne Muscular Dystrophy Therapeutics Market Size Share by Players in 2017
Figure EU Duchenne Muscular Dystrophy Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table EU Duchenne Muscular Dystrophy Therapeutics Market Size (Million USD) by Players (2012-2017)
Figure EU Duchenne Muscular Dystrophy Therapeutics Market Size Share by Players in 2016
Figure EU Duchenne Muscular Dystrophy Therapeutics Market Size Share by Players in 2017
Figure Japan Duchenne Muscular Dystrophy Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table Japan Duchenne Muscular Dystrophy Therapeutics Market Size (Million USD) by Players (2012-2017)
Figure Japan Duchenne Muscular Dystrophy Therapeutics Market Size Share by Players in 2016
Figure Japan Duchenne Muscular Dystrophy Therapeutics Market Size Share by Players in 2017
Figure China Duchenne Muscular Dystrophy Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table China Duchenne Muscular Dystrophy Therapeutics Market Size (Million USD) by Players (2012-2017)
Figure China Duchenne Muscular Dystrophy Therapeutics Market Size Share by Players in 2016
Figure China Duchenne Muscular Dystrophy Therapeutics Market Size Share by Players in 2017
Figure India Duchenne Muscular Dystrophy Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table India Duchenne Muscular Dystrophy Therapeutics Market Size (Million USD) by Players (2012-2017)
Figure India Duchenne Muscular Dystrophy Therapeutics Market Size Share by Players in 2016
Figure India Duchenne Muscular Dystrophy Therapeutics Market Size Share by Players in 2017
Figure Southeast Asia Duchenne Muscular Dystrophy Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table Southeast Asia Duchenne Muscular Dystrophy Therapeutics Market Size (Million USD) by Players (2012-2017)
Figure Southeast Asia Duchenne Muscular Dystrophy Therapeutics Market Size Share by Players in 2016
Figure Southeast Asia Duchenne Muscular Dystrophy Therapeutics Market Size Share by Players in 2017
Figure Global Duchenne Muscular Dystrophy Therapeutics Market Size (Million USD) by Regions (2017-2022)
Table Global Duchenne Muscular Dystrophy Therapeutics Market Size (Million USD) by Regions (2017-2022)
Figure Global Duchenne Muscular Dystrophy Therapeutics Market Size Share by Regions in 2017
Figure Global Duchenne Muscular Dystrophy Therapeutics Market Size Share by Regions in 2022
Figure United States Duchenne Muscular Dystrophy Therapeutics Revenue (Million USD) and Growth Rate (2017-2022)
Figure EU Duchenne Muscular Dystrophy Therapeutics Revenue (Million USD) and Growth Rate (2017-2022)
Figure Japan Duchenne Muscular Dystrophy Therapeutics Revenue (Million USD) and Growth Rate (2017-2022)
Figure China Duchenne Muscular Dystrophy Therapeutics Revenue (Million USD) and Growth Rate (2017-2022)
Figure India Duchenne Muscular Dystrophy Therapeutics Revenue (Million USD) and Growth Rate (2017-2022)
Figure Southeast Asia Duchenne Muscular Dystrophy Therapeutics Revenue (Million USD) and Growth Rate (2017-2022)
Table Global Duchenne Muscular Dystrophy Therapeutics Market Size (Million USD) by Type (2017-2022)
Figure Global Duchenne Muscular Dystrophy Therapeutics Market Size Share by Type in 2017
Figure Global Duchenne Muscular Dystrophy Therapeutics Market Size Share by Type in 2022
Table Global Duchenne Muscular Dystrophy Therapeutics Market Size (Million USD) by Application (2017-2022)
Figure Global Duchenne Muscular Dystrophy Therapeutics Market Size (Million USD) by Application in 2017
Figure Global Duchenne Muscular Dystrophy Therapeutics Market Size (Million USD) by Application in 2022
Figure Duchenne Muscular Dystrophy Therapeutics Product Scope
Figure Global Duchenne Muscular Dystrophy Therapeutics Market Size (Million USD) (2012-2017)
Table Global Duchenne Muscular Dystrophy Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Global Duchenne Muscular Dystrophy Therapeutics Market Share by Regions in 2016
Figure United States Duchenne Muscular Dystrophy Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure EU Duchenne Muscular Dystrophy Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Japan Duchenne Muscular Dystrophy Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure China Duchenne Muscular Dystrophy Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure India Duchenne Muscular Dystrophy Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Southeast Asia Duchenne Muscular Dystrophy Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Global Duchenne Muscular Dystrophy Therapeutics Market Share by Type in 2016
Figure Pain Management Drugs Market Size (Million USD) and Growth Rate (2012-2017)
Figure Corticosteroids Market Size (Million USD) and Growth Rate (2012-2017)
Figure Prednisolone Market Size (Million USD) and Growth Rate (2012-2017)
Figure Prednisone Market Size (Million USD) and Growth Rate (2012-2017)
Figure Deflazacort Market Size (Million USD) and Growth Rate (2012-2017)
Figure Global Duchenne Muscular Dystrophy Therapeutics Market Share by Application in 2016
Table Key Downstream Customer in Hospitals
Figure Duchenne Muscular Dystrophy Therapeutics Market Size (Million USD) and Growth Rate in Hospitals (2012-2017)
Table Key Downstream Customer in Clinics
Figure Duchenne Muscular Dystrophy Therapeutics Market Size (Million USD) and Growth Rate in Clinics (2012-2017)
Table Key Downstream Customer in Home Care Settings
Figure Duchenne Muscular Dystrophy Therapeutics Market Size (Million USD) and Growth Rate in Home Care Settings (2012-2017)
Table Duchenne Muscular Dystrophy Therapeutics Market Size (Million USD) by Players (2016 and 2017)
Figure Duchenne Muscular Dystrophy Therapeutics Market Size Share by Players in 2016
Figure Duchenne Muscular Dystrophy Therapeutics Market Size Share by Players in 2017
Table Bristol-Myers Squibb Company Basic Information List
Table Duchenne Muscular Dystrophy Therapeutics Business Revenue (Million USD) of Bristol-Myers Squibb Company (2012-2017)
Figure Bristol-Myers Squibb Company Duchenne Muscular Dystrophy Therapeutics Business Revenue Market Share in 2016
Table FibroGen Basic Information List
Table Duchenne Muscular Dystrophy Therapeutics Business Revenue (Million USD) of FibroGen (2012-2017)
Figure FibroGen Duchenne Muscular Dystrophy Therapeutics Business Revenue Market Share in 2016
Table ITALFARMACO Basic Information List
Table Duchenne Muscular Dystrophy Therapeutics Business Revenue (Million USD) of ITALFARMACO (2012-2017)
Figure ITALFARMACO Duchenne Muscular Dystrophy Therapeutics Business Revenue Market Share in 2016
Table Marathon Pharmaceuticals Basic Information List
Table Duchenne Muscular Dystrophy Therapeutics Business Revenue (Million USD) of Marathon Pharmaceuticals (2012-2017)
Figure Marathon Pharmaceuticals Duchenne Muscular Dystrophy Therapeutics Business Revenue Market Share in 2016
Table NS Pharma Basic Information List
Table Duchenne Muscular Dystrophy Therapeutics Business Revenue (Million USD) of NS Pharma (2012-2017)
Figure NS Pharma Duchenne Muscular Dystrophy Therapeutics Business Revenue Market Share in 2016
Table PTC Therapeutics Basic Information List
Table Duchenne Muscular Dystrophy Therapeutics Business Revenue (Million USD) of PTC Therapeutics (2012-2017)
Figure PTC Therapeutics Duchenne Muscular Dystrophy Therapeutics Business Revenue Market Share in 2016
Table Pfizer Basic Information List
Table Duchenne Muscular Dystrophy Therapeutics Business Revenue (Million USD) of Pfizer (2012-2017)
Figure Pfizer Duchenne Muscular Dystrophy Therapeutics Business Revenue Market Share in 2016
Table ReveraGen BioPharma Basic Information List
Table Duchenne Muscular Dystrophy Therapeutics Business Revenue (Million USD) of ReveraGen BioPharma (2012-2017)
Figure ReveraGen BioPharma Duchenne Muscular Dystrophy Therapeutics Business Revenue Market Share in 2016
Table Santhera Pharmaceuticals Basic Information List
Table Duchenne Muscular Dystrophy Therapeutics Business Revenue (Million USD) of Santhera Pharmaceuticals (2012-2017)
Figure Santhera Pharmaceuticals Duchenne Muscular Dystrophy Therapeutics Business Revenue Market Share in 2016
Table Sarepta Therapeutics Basic Information List
Table Duchenne Muscular Dystrophy Therapeutics Business Revenue (Million USD) of Sarepta Therapeutics (2012-2017)
Figure Sarepta Therapeutics Duchenne Muscular Dystrophy Therapeutics Business Revenue Market Share in 2016
Table Global Duchenne Muscular Dystrophy Therapeutics Market Size (Million USD) by Type (2012-2017)
Figure Global Duchenne Muscular Dystrophy Therapeutics Market Size Share by Type in 2012
Figure Global Duchenne Muscular Dystrophy Therapeutics Market Size Share by Type in 2013
Figure Global Duchenne Muscular Dystrophy Therapeutics Market Size Share by Type in 2014
Figure Global Duchenne Muscular Dystrophy Therapeutics Market Size Share by Type in 2015
Figure Global Duchenne Muscular Dystrophy Therapeutics Market Size Share by Type in 2016
Figure Global Duchenne Muscular Dystrophy Therapeutics Market Size Share by Type in 2017
Table Global Duchenne Muscular Dystrophy Therapeutics Market Size (Million USD) by Application (2012-2017)
Figure Global Duchenne Muscular Dystrophy Therapeutics Market Size (Million USD) by Application in 2012
Figure Global Duchenne Muscular Dystrophy Therapeutics Market Size (Million USD) by Application in 2013
Figure Global Duchenne Muscular Dystrophy Therapeutics Market Size (Million USD) by Application in 2014
Figure Global Duchenne Muscular Dystrophy Therapeutics Market Size (Million USD) by Application in 2015
Figure Global Duchenne Muscular Dystrophy Therapeutics Market Size (Million USD) by Application in 2016
Figure Global Duchenne Muscular Dystrophy Therapeutics Market Size (Million USD) by Application in 2017
Table Top Consumer/End Users of Duchenne Muscular Dystrophy Therapeutics
Figure United States Duchenne Muscular Dystrophy Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table United States Duchenne Muscular Dystrophy Therapeutics Market Size (Million USD) by Players (2012-2017)
Figure United States Duchenne Muscular Dystrophy Therapeutics Market Size Share by Players in 2016
Figure United States Duchenne Muscular Dystrophy Therapeutics Market Size Share by Players in 2017
Figure EU Duchenne Muscular Dystrophy Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table EU Duchenne Muscular Dystrophy Therapeutics Market Size (Million USD) by Players (2012-2017)
Figure EU Duchenne Muscular Dystrophy Therapeutics Market Size Share by Players in 2016
Figure EU Duchenne Muscular Dystrophy Therapeutics Market Size Share by Players in 2017
Figure Japan Duchenne Muscular Dystrophy Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table Japan Duchenne Muscular Dystrophy Therapeutics Market Size (Million USD) by Players (2012-2017)
Figure Japan Duchenne Muscular Dystrophy Therapeutics Market Size Share by Players in 2016
Figure Japan Duchenne Muscular Dystrophy Therapeutics Market Size Share by Players in 2017
Figure China Duchenne Muscular Dystrophy Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table China Duchenne Muscular Dystrophy Therapeutics Market Size (Million USD) by Players (2012-2017)
Figure China Duchenne Muscular Dystrophy Therapeutics Market Size Share by Players in 2016
Figure China Duchenne Muscular Dystrophy Therapeutics Market Size Share by Players in 2017
Figure India Duchenne Muscular Dystrophy Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table India Duchenne Muscular Dystrophy Therapeutics Market Size (Million USD) by Players (2012-2017)
Figure India Duchenne Muscular Dystrophy Therapeutics Market Size Share by Players in 2016
Figure India Duchenne Muscular Dystrophy Therapeutics Market Size Share by Players in 2017
Figure Southeast Asia Duchenne Muscular Dystrophy Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table Southeast Asia Duchenne Muscular Dystrophy Therapeutics Market Size (Million USD) by Players (2012-2017)
Figure Southeast Asia Duchenne Muscular Dystrophy Therapeutics Market Size Share by Players in 2016
Figure Southeast Asia Duchenne Muscular Dystrophy Therapeutics Market Size Share by Players in 2017
Figure Global Duchenne Muscular Dystrophy Therapeutics Market Size (Million USD) by Regions (2017-2022)
Table Global Duchenne Muscular Dystrophy Therapeutics Market Size (Million USD) by Regions (2017-2022)
Figure Global Duchenne Muscular Dystrophy Therapeutics Market Size Share by Regions in 2017
Figure Global Duchenne Muscular Dystrophy Therapeutics Market Size Share by Regions in 2022
Figure United States Duchenne Muscular Dystrophy Therapeutics Revenue (Million USD) and Growth Rate (2017-2022)
Figure EU Duchenne Muscular Dystrophy Therapeutics Revenue (Million USD) and Growth Rate (2017-2022)
Figure Japan Duchenne Muscular Dystrophy Therapeutics Revenue (Million USD) and Growth Rate (2017-2022)
Figure China Duchenne Muscular Dystrophy Therapeutics Revenue (Million USD) and Growth Rate (2017-2022)
Figure India Duchenne Muscular Dystrophy Therapeutics Revenue (Million USD) and Growth Rate (2017-2022)
Figure Southeast Asia Duchenne Muscular Dystrophy Therapeutics Revenue (Million USD) and Growth Rate (2017-2022)
Table Global Duchenne Muscular Dystrophy Therapeutics Market Size (Million USD) by Type (2017-2022)
Figure Global Duchenne Muscular Dystrophy Therapeutics Market Size Share by Type in 2017
Figure Global Duchenne Muscular Dystrophy Therapeutics Market Size Share by Type in 2022
Table Global Duchenne Muscular Dystrophy Therapeutics Market Size (Million USD) by Application (2017-2022)
Figure Global Duchenne Muscular Dystrophy Therapeutics Market Size (Million USD) by Application in 2017
Figure Global Duchenne Muscular Dystrophy Therapeutics Market Size (Million USD) by Application in 2022
